English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China Journal article
Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China[J]. Diabetes Therapy, 2023, 14(1), 93-107.
Authors:  Liu, Lei;  Ruan, Zhen;  Ung, Carolina Oi Lam;  Zhang, Yawen;  Shen, Yang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:2.8/2.9 | Submit date：2023/01/08
Cost-effectiveness Analysis  Type 2 Diabetes  Glucagon-like Peptide-1 Analogue  Semaglutide  Peg-loxenatide  China  
Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China Journal article
Ruan, Zhen, Ung, Carolina Oi Lam, Shen, Yang, Zhang, Yawen, Wang, Weihao, Luo, Jingyi, Zou, Huimin, Xue, Yan, Wang, Yao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China[J]. DIABETES THERAPY, 2022, 13(10), 1737-1753.
Authors:  Ruan, Zhen;  Ung, Carolina Oi Lam;  Shen, Yang;  Zhang, Yawen;  Wang, Weihao; et al.
Favorite | TC[WOS]:5 TC[Scopus]:8  IF:2.8/2.9 | Submit date：2022/08/28
China  Cost-effectiveness  Diabetes  Dulaglutide  Semaglutide  
Low-magnitude high-frequency vibration decreases body weight gain and increases muscle strength by enhancing the p38 and ampk pathways in db/db mice Journal article
Ren,Zhitao, Lan,Qingping, Chen,Yan, Chan,Yuet Wa Judy, Mahady,Gail B., Lee,Simon Ming Yuen. Low-magnitude high-frequency vibration decreases body weight gain and increases muscle strength by enhancing the p38 and ampk pathways in db/db mice[J]. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2020, 13, 979-989.
Authors:  Ren,Zhitao;  Lan,Qingping;  Chen,Yan;  Chan,Yuet Wa Judy;  Mahady,Gail B.; et al.
Favorite | TC[WOS]:9 TC[Scopus]:12  IF:2.8/3.3 | Submit date：2021/03/01
Ampkα  Low-magnitude High-frequency Vibration  Mitochondrial Biogenesis  P38  Type 2 Diabetes Mellitus